Antonio Alberti

617 total citations
24 papers, 377 citations indexed

About

Antonio Alberti is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Antonio Alberti has authored 24 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 10 papers in Pathology and Forensic Medicine and 5 papers in Immunology. Recurrent topics in Antonio Alberti's work include Chronic Lymphocytic Leukemia Research (13 papers), Lymphoma Diagnosis and Treatment (9 papers) and Immunodeficiency and Autoimmune Disorders (4 papers). Antonio Alberti is often cited by papers focused on Chronic Lymphocytic Leukemia Research (13 papers), Lymphoma Diagnosis and Treatment (9 papers) and Immunodeficiency and Autoimmune Disorders (4 papers). Antonio Alberti collaborates with scholars based in Italy, United States and Spain. Antonio Alberti's co-authors include Stefano Molica, Yuet Wai Kan, Judy C. Chang, Franco Mandelli, Maurizio Martelli, Lucio Trodella, Joan Carles Reverter, Michele Fiore, Edy Ippolito and Vincenzo Liso and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and Blood.

In The Last Decade

Antonio Alberti

23 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antonio Alberti Italy 11 263 227 112 100 53 24 377
G. Bellesi Italy 11 88 0.3× 172 0.8× 78 0.7× 52 0.5× 30 0.6× 16 336
Prashant Jani Canada 12 42 0.2× 209 0.9× 35 0.3× 42 0.4× 8 0.2× 23 498
Dolores Hernández‐Maraver Spain 10 58 0.2× 141 0.6× 27 0.2× 70 0.7× 81 1.5× 27 386
Julia von Tresckow Germany 9 333 1.3× 303 1.3× 128 1.1× 58 0.6× 92 1.7× 35 391
S Kotlarek-Haus Poland 6 303 1.2× 236 1.0× 152 1.4× 37 0.4× 61 1.2× 23 355
A. Perin Italy 12 76 0.3× 82 0.4× 162 1.4× 41 0.4× 16 0.3× 24 446
Chiara Vendramin Italy 9 206 0.8× 166 0.7× 134 1.2× 34 0.3× 95 1.8× 19 377
Masato Obara Japan 10 89 0.3× 78 0.3× 98 0.9× 32 0.3× 123 2.3× 20 301
Luděk Raida Czechia 12 82 0.3× 125 0.6× 114 1.0× 34 0.3× 142 2.7× 58 391
G Brittinger Germany 8 66 0.3× 144 0.6× 61 0.5× 33 0.3× 37 0.7× 22 251

Countries citing papers authored by Antonio Alberti

Since Specialization
Citations

This map shows the geographic impact of Antonio Alberti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Alberti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Alberti more than expected).

Fields of papers citing papers by Antonio Alberti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Alberti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Alberti. The network helps show where Antonio Alberti may publish in the future.

Co-authorship network of co-authors of Antonio Alberti

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Alberti. A scholar is included among the top collaborators of Antonio Alberti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Alberti. Antonio Alberti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ramella, Sara, Michele Fiore, Maria Cristina Zappa, et al.. (2017). Local Control and Toxicity of Adaptive Radiotherapy Using Weekly CT Imaging: Results from the LARTIA Trial in Stage III NSCLC. Journal of Thoracic Oncology. 12(7). 1122–1130. 50 indexed citations
2.
Domati, Federica, Stefania Maffei, Shaniko Kaleci, et al.. (2013). Incidence, clinical features and possible etiology of early onset (≤40 years) colorectal neoplasms. Internal and Emergency Medicine. 9(6). 623–31. 7 indexed citations
3.
Ramella, Sara, Antonio Alberti, Michele Fiore, et al.. (2013). Erlotinib and Concurrent Chemoradiation in Pretreated NSCLC Patients: Radiobiological Basis and Clinical Results. BioMed Research International. 2013. 1–5. 11 indexed citations
4.
5.
6.
Alberti, Antonio, Evelina Miele, Sara Ramponi, et al.. (2006). Concurrent radiotherapy (RT) and chemotherapy (CT) with oxaliplatin as primary treatment of advanced rectal cancer: a phase II study. Journal of Clinical Oncology. 24(18_suppl). 13507–13507. 1 indexed citations
7.
Craxı̀, Antonio, G. Idéo, Luigi Demelia, et al.. (2003). 15 Open, multicenter, randomized, controlled trial to compare safety and efficacy of r-hIFN beta 1a alone or in combination with ribavirin in HCV naiv patients. Digestive and Liver Disease. 35. A14–A14. 2 indexed citations
8.
Callea, Vincenzo, et al.. (1994). Comparison of younger versus older B‐cell chronic lymphocytic leukemia patients for clinical presentation and prognosis. A retrospective study of 53 cases. European Journal Of Haematology. 52(4). 216–221. 26 indexed citations
9.
Molica, Stefano, Antonio Alberti, Maura Brugiatelli, et al.. (1992). Presenting features and prognosis of B-cell chronic lymphocytic leukemia patients less than 50 years old [letter; comment]. Blood. 79(11). 3093–3094. 1 indexed citations
10.
Molica, S., et al.. (1990). Chronic myelomonocytic leukemia: A test of a proposed staging system. American Journal of Hematology. 35(2). 129–130. 5 indexed citations
11.
Molica, Stefano, Joan Carles Reverter, Antonio Alberti, & Emilio Montserrat. (1990). Timing of diagnosis and lymphocyte accumulation patterns in chronic lymphocytic leukemia: Analysis of their clinical significance. European Journal Of Haematology. 44(5). 277–281. 18 indexed citations
12.
Mandelli, Franco, A. Covelli, Matteo Luciani, et al.. (1989). Chronic lymphocytic leukemia (CLL) in younger adults: A retrospective study of 133 cases. Hematological Oncology. 7(2). 127–137. 19 indexed citations
13.
Molica, Stefano & Antonio Alberti. (1988). Investigation of nuclear clefts as a prognostic parameter in chronic lymphocytic leukemia. European Journal Of Haematology. 41(1). 62–65. 16 indexed citations
14.
Alberti, Antonio, et al.. (1987). Prognostic value of the lymphocyte doubling time in chronic lymphocytic leukemia. Cancer. 60(11). 2712–2716. 99 indexed citations
15.
Mandelli, Franco, Giulio Rossi, P Mancini, et al.. (1987). Prognosis in chronic lymphocytic leukemia: a retrospective multicentric study from the GIMEMA group.. Journal of Clinical Oncology. 5(3). 398–406. 47 indexed citations
16.
Molica, Stefano & Antonio Alberti. (1986). Prognostic value of "total tumor mass score" (TTM): a retrospective analysis of 130 patients with chronic lymphocytic leukemia.. PubMed. 72(6). 559–64. 1 indexed citations
17.
Molica, Stefano & Antonio Alberti. (1986). Prognostic Value of « Total Tumor Mass Score » (TTM): A Retrospective Analysis of 130 Patients with Chronic Lymphocytic Leukemia. Tumori Journal. 72(6). 559–564. 3 indexed citations
18.
Alberti, Antonio, et al.. (1985). Serum antibodies against coxsackie B1–6 viruses in type 1 diabetics. Acta Diabetologica. 22(1). 33–38. 10 indexed citations
19.
Molica, Stefano, et al.. (1984). Prognosis of Chronic Lymphocytic Leukemia: Analysis of One Hundred Cases. Tumori Journal. 70(5). 399–402. 7 indexed citations
20.
Chang, Judy C., Antonio Alberti, & Yuet Wai Kan. (1983). A β-thalassemia ledon abolishes the sameMstII site as the sickle mutation. Nucleic Acids Research. 11(22). 7789–7794. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. Bellesi Breakdown of academic impact, for papers by Prashant Jani Breakdown of academic impact, for papers by Dolores Hernández‐Maraver Breakdown of academic impact, for papers by Julia von Tresckow Breakdown of academic impact, for papers by S Kotlarek-Haus Breakdown of academic impact, for papers by A. Perin Breakdown of academic impact, for papers by Chiara Vendramin Breakdown of academic impact, for papers by Masato Obara Breakdown of academic impact, for papers by Luděk Raida Breakdown of academic impact, for papers by G Brittinger
Rankless by CCL
2026